Hyperhomocysteinemia as a Risk Factor for Venous Thrombosis

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Clinical Chemistry and Laboratory Medicine

• Publication date

  2001-01-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.1515/CCLM.2001.117PMID 11592438
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Homocysteine and Venous Thrombosis: Outline of a Vitamin Intervention Trial

  2000cited by this paper
• The Elevated Risk for Venous Thrombosis in Persons with Hyperhomocysteinemia Is not Reflected by the Endogenous Thrombin Potential

  1999cited by this paper
• Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocystinemia in normal and thromboembolic subjects.

  1999cited by this paper
• Hormone Replacement Therapy and Circulating ICAM-1 in Postmenopausal Women

  1999cited by this paper
• Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment.

  1999cited by this paper
• The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels.

  1999cited by this paper
• Venous Thromboembolic Disease and the Prothrombin, Methylene Tetrahydrofolate Reductase and Factor V Genes

  1999cited by this paper
• A second mutation in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease

  1999cited by this paper
• Prevalence of mild hyperhomocysteinaemia and association with thrombophilic genotypes (factor V Leiden and prothrombin G20210A) in Italian patients with venous thromboembolic disease

  1999cited by this paper
• Lowering blood homocysteine with folic acid based supplements: meta›analysis of randomised trials

  1998cited by this paper
• Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials

  1998cited by this paper
• Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers.

  1998cited by this paper
• The Methylenetetrahydrofolate Reductase TT677 Genotype Is Associated with Venous Thrombosis Independently of the Coexistence of the FV Leiden and the Prothrombin

  1998cited by this paper
• Moderate hyperhomocysteinemia is a highly prevalent defect in Spanish patients with venous thromboembolic disease.

  1998cited by this paper
• Thermolabile Methylenetetrahydrofolate Reductase and Factor V Leiden in the Risk of Deep-Vein Thrombosis

  1998influential reference
• Relation of three genetic traits to venous thrombosis in an African-American population.

  1998cited by this paper
• Homocysteine and atherothrombosis.

  1998cited by this paper
• Hyperhomocysteinemia and Venous Thrombosis: A Meta-analysis

  1998cited by this paper
• Hyperhomocysteinemia Is a Risk Factor of Recurrent Venous Thromboembolism

  1998influential reference
• MTHFR association with arteriosclerotic vascular disease?

  1998cited by this paper
• Plasma levels of activated protein C in healthy subjects and patients with previous venous thromboembolism: relationships with plasma homocysteine levels.

  1998cited by this paper
• Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism.

  1997influential reference
• Levels of Prothrombin Fragment F1+2 in Patients with Hyperhomocysteinemia and a History of Venous Thromboembolism

  1997cited by this paper
• The Mutation Ala677→Val in the Methylene Tetrahydrofolate Reductase Gene: A Risk Factor for Arterial Disease and Venous Thrombosis

  1997cited by this paper
• The C677T MTHFR variant and the risk of venous thrombosis.

  1997cited by this paper
• Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second‐ and third‐generation oral contraceptives

  1997cited by this paper
• A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:Q506).

  1997cited by this paper
• Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

  1996cited by this paper
• Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

  1996cited by this paper
• Plasma homocysteine levels in patients with deep venous thrombosis.

  1995cited by this paper
• A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

  1995cited by this paper
• Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?

  1995cited by this paper
• Prevalence of Moderate Hyperhomocysteinemia in Patients with Early-Onset Venous and Arterial Occlusive Disease

  1995cited by this paper
• Mutation in blood coagulation factor V associated with resistance to activated protein C

  1994influential reference
• High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.

  1994cited by this paper
• Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis.

  1993cited by this paper
• Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells.

  1993cited by this paper
• Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells.

  1993cited by this paper
• Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.

  1993cited by this paper
• Elevated total plasma homocysteine, a risk factor for thrombosis. Relation to coagulation and fibrinolytic parameters.

  1993cited by this paper
• An atherogenic stimulus homocysteine inhibits cofactor activity of thrombomodulin and enhances thrombomodulin expression in human umbilical vein endothelial cells.

  1992cited by this paper
• [Plasma homocysteine assay in the exploration of thrombosis in young subjects].

  1991cited by this paper
• Plasma homocysteine in venous thromboembolism.

  1991cited by this paper
• Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine.

  1991cited by this paper
• Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells.

  1990cited by this paper
• Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.

  1986cited by this paper
• The natural history of homocystinuria due to cystathionine beta-synthase deficiency.

  1985cited by this paper

• Cerebral venous thrombosis associated with hyperhomocysteinemia and iron-deficiency anemia induced by autoimmune gastritis: A case report and literature review

  2022cites this paper
• A Case of Systemic Lupus Erythematosus without Antiphospholipid Syndrome Causing Superior Vena Cava Syndrome

  2021cites this paper
• Features of the content of homocysteine and thyroid hormones in pregnant women with uterine myoma

  2020cites this paper
• JScholar Publishers Cystathionine-β-Synthase Deficiency Revealed by Recurrent Thrombosis in Young Patients: A Diagnosis often Missed

  2020cites this paper
• Homocysteine inhibits the viability and migration ability of human umbilical vein endothelial cells by downregulating the expression of vascular endothelial growth factor

  2019cites this paper
• Blood homocysteine levels are increased in hepatocellular carcinoma patients with portal vein thrombosis. A single centre retrospective cohort study

  2018cites this paper
• The Relationship between Obesity and Oxidative Stress and Cardiac Markers

  2015cites this paper
• Homocysteine levels in patients of type 2 diabetes mellitus with diabetic nephropathy and its clinical implications

  2015cites this paper
• A rare cause of superior vena cava syndrome

  2013cites this paper
• A comparative biochemical study on the non diabetic obese and non obese subjects with cardiovascular disease

  2013cites this paper
• vascular function in mice Effect of Mthfr genotype on diet-induced hyperhomocysteinemia and

  2013cites this paper
• Homocysteine and venous thromboembolism—Is there any link?

  2013cites this paper
• Segmental renal artery thrombosis secondary to methylene tetrahydrofolate reductase mutation: an unusual presentation.

  2012cites this paper
• Thrombosis in Systemic Lupus Erythematosus: A Review Article

  2012cites this paper
• Deep Venous Thrombosis in Breast Cancer Patients Using Tamoxifen, a Hypothesis

  2011cites this paper
• Portal vein thrombosis in Egyptian patients with liver cirrhosis: Role of methylenetetrahydrofolate reductase C677T gene mutation

  2010cites this paper
• Hiperhomocisteinemia. Panorama actual y contribución del ratón a su estudio

  2010cites this paper
• Inherited Thrombophilia: Key Points for Genetic Counseling

  2007cites this paper
• Does the oxidation of methionine in thrombomodulin contribute to the hypercoaguable state of smokers and diabetics?

  2007cites this paper
• Methylenetetrahydrofolate reductase C677T polymorphism and liver fibrosis progression in patients with recurrent hepatitis C

  2007cites this paper
• Safety issues and prospects for future generations of PPAR modulators.

  2007cites this paper
• Newborn Screening Fact Sheets

  2006cites this paper
• Thrombophilia in children with venous thromboembolic disease.

  2006cites this paper
• Homocysteine concentrations in patients with diabetes mellitus – relationship to microvascular and macrovascular disease

  2005cites this paper
• Homocysteine-induced thrombosis

  2004cites this paper
• Risk factors for catheter-related thrombosis in cancer patients.

  2004cites this paper
• Genetic thrombophilia.

  2004cites this paper
• Homocysteine: is it a clinically important cardiovascular risk factor?

  2004cites this paper
• The dose-response relation between serum homocysteine and cardiovascular disease: implications for treatment and screening

  2004cites this paper
• Is subclinical hypothyroidism associated with hyperhomocysteinemia?

  2004cites this paper
• High-level multiplex genotyping of polymorphisms involved in folate or homocysteine metabolism by matrix-assisted laser desorption/ionization mass spectrometry.

  2004cites this paper
• HOMOCYSTEINE: A RISK FACTOR WORTH TREATING A CONCISE UPDATE OF IMPORTANT ISSUES CONCERNING NATURAL HEALTH INGREDIENTS

  2004cites this paper
• Effect of Mthfr genotype on diet-induced hyperhomocysteinemia and vascular function in mice.

  2004cites this paper
• Homocysteine - A Risk Factor for Vascular Diseases: Guidelines for the Clinical Practice

  2004cites this paper
• The effect of homocysteine reduction by B-vitamin supplementation on markers of endothelial dysfunction

  2004cites this paper
• [Hyperhomocysteinemia-related cerebral venous thrombosis].

  2003cites this paper
• Homocysteine: Chemistry, metabolism and roles in pathophysiology processes

  2003cites this paper
• Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease 1

  2003cites this paper
• Hyperhomocysteinemia and End-Stage Renal Disease: Determinants and Association with Cardiovascular Disease in Tunisian Patients

  2003cites this paper
• Methylenetetrahydrofolate Reductase Gene Polymorphism and Glucocorticoid Intake in Children with ALL and Aseptic Osteonecrosis

  2003cites this paper
• Functional Vitamin B12 Deficiency and Determination of Holotranscobalamin in Populations at Risk

  2003cites this paper
• Familial hyperhomocysteinemia: multiple venous thrombosis in four generations of a family

  2003cites this paper
• Vegetarian lifestyle and monitoring of vitamin B-12 status.

  2002cites this paper
• Interaction Between Hyperhomocysteinemia, Mutated Methylenetetrahydrofolatereductase (MTHFR) and Inherited Thrombophilic Factors in Recurrent Venous Thrombosis

  2002cites this paper
• Magnetic Resonance Imaging in Pediatric Stroke

  2002cites this paper
• Risk Factors for Coronary Disease: the Time for a Paradigm Shift?

  2001cites this paper
• Thrombophilia: a genetic predisposition to thrombosis.

  1999cites this paper
• HOMOCYSTINURIA The term " homocystinuria " designates a biochemical abnormality

  year unknowncites this paper